 50 PM / Updated 5 minutes ago BRIEF-Anthera Announces Positive Outcome Of Second Interim Futility Analysis In The Phase 3 Sollpura Study Reuters Staff 1 Min Read 
Jan 22 (Reuters) - Anthera Pharmaceuticals Inc: 
* ANTHERA ANNOUNCES POSITIVE OUTCOME OF SECOND INTERIM FUTILITY ANALYSIS IN THE PHASE 3 RESULT CLINICAL STUDY OF SOLLPURA: STUDY ON SCHEDULE FOR TOPLINE DATA THIS QUARTER 
* ANTHERA PHARMACEUTICALS INC - ON TRACK TO REPORT TOPLINE DATA LATER THIS QUARTERâ€‹ FROM RESULT STUDY Source text for Eikon: Further company coverage: